Widespread Diabetes Drug Metformin Would possibly Assist Battle COVID-19

8 Min Read
8 Min Read

Metformin has established itself as a first-line drug for kind 2 diabetes. Along with decreasing blood sugar ranges, this drug could lengthen lifespan, decrease coronary heart danger, decrease hypertension, and supply different well being advantages.

Now, researchers are additionally observing that metformin (offered underneath commerce names akin to Glucophage, Glumezza, and Fortamet) may additionally scale back the chance of age-related macular degeneration (AMD), the main reason behind imaginative and prescient loss in folks over 50. The illness, which places diabetics at increased danger, impacts about 2.1 million folks nationwide, in keeping with the Nationwide Institutes of Well being.

See extra analysis on metformin and AMD

In a report offered Oct. 28 on the American Academy of Ophthalmology annual assembly, researchers in Taiwan analyzed well being knowledge for 45,524 diabetic sufferers taking metformin, in contrast with 22,681 sufferers not taking metformin. All individuals had new-onset kind 2 diabetes. A retrospective examine was carried out from January 2001 to December 2013.

Scientists discovered that individuals who took metformin had a few 50 % decrease danger of growing AMD than those that did not take it.

Share This Article
Leave a comment